A detailed history of Charles Schwab Investment Management Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 277,275 shares of QURE stock, worth $4.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277,275
Previous 260,811 6.31%
Holding current value
$4.81 Million
Previous $1.17 Million 16.95%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.78 - $10.12 $62,233 - $166,615
16,464 Added 6.31%
277,275 $1.37 Million
Q2 2024

Aug 12, 2024

BUY
$4.39 - $5.43 $111,159 - $137,493
25,321 Added 10.75%
260,811 $1.17 Million
Q1 2024

May 08, 2024

BUY
$4.82 - $6.93 $63,146 - $90,789
13,101 Added 5.89%
235,490 $1.22 Million
Q4 2023

Feb 06, 2024

SELL
$5.63 - $8.27 $104,847 - $154,012
-18,623 Reduced 7.73%
222,389 $1.51 Million
Q3 2023

Nov 08, 2023

BUY
$6.71 - $11.83 $127,389 - $224,592
18,985 Added 8.55%
241,012 $1.62 Million
Q2 2023

Aug 09, 2023

BUY
$11.12 - $22.2 $33,437 - $66,755
3,007 Added 1.37%
222,027 $2.54 Million
Q1 2023

May 11, 2023

SELL
$18.7 - $23.07 $10,079 - $12,434
-539 Reduced 0.25%
219,020 $4.41 Million
Q4 2022

Feb 13, 2023

BUY
$18.12 - $27.32 $132,384 - $199,599
7,306 Added 3.44%
219,559 $4.98 Million
Q3 2022

Nov 14, 2022

BUY
$16.98 - $25.54 $555,008 - $834,800
32,686 Added 18.2%
212,253 $3.98 Million
Q2 2022

Aug 15, 2022

SELL
$13.15 - $20.45 $27,733 - $43,129
-2,109 Reduced 1.16%
179,567 $3.35 Million
Q1 2022

May 13, 2022

BUY
$14.54 - $21.5 $65,051 - $96,191
4,474 Added 2.52%
181,676 $3.28 Million
Q4 2021

Feb 11, 2022

BUY
$20.24 - $36.01 $41,775 - $74,324
2,064 Added 1.18%
177,202 $3.68 Million
Q3 2021

Nov 16, 2021

SELL
$26.01 - $38.22 $200,667 - $294,867
-7,715 Reduced 4.22%
175,138 $5.61 Million
Q2 2021

Aug 16, 2021

BUY
$29.97 - $37.17 $194,445 - $241,158
6,488 Added 3.68%
182,853 $5.63 Million
Q1 2021

May 17, 2021

BUY
$29.24 - $42.03 $221,463 - $318,335
7,574 Added 4.49%
176,365 $5.94 Million
Q4 2020

Feb 16, 2021

BUY
$35.35 - $50.67 $80,562 - $115,476
2,279 Added 1.37%
168,791 $6.1 Million
Q3 2020

Nov 13, 2020

BUY
$35.98 - $47.66 $5.99 Million - $7.94 Million
166,512 New
166,512 $6.13 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $811M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.